If you have registered for an event, you may log in to manage your registration.
Researchers at BioGrid Australia member and/or collaborator institutions may submit new or amended applications requesting access to data connected to BioGrid using our online application system.
Authorised researchers can explore and visualise data on specified connected data utilising a web interface.
Authorised researchers can utilise this comprehensive data and statistical analysis application to analyse, explore and visualise connected datasets for approved audit and research projects.
The company is governed by an independent board of directors whose main focus is the ongoing financial sustainability of BioGrid so that it can continue to provide this valuable service to the Australian clinical and research communities.
MBBS, MPH, FAFPHM, MAICD
Director of BioGrid Australia since October 2017; Chair since September 2018Current Role: Director – Health and Biosecurity, CSIRO, since 2015
Dr Rob Grenfell, a Public Health Physician, is the Director of CSIRO’s Health and Biosecurity Business Unit. Leading a broad portfolio covering Nutrition, eHealth, Medtech and Diagnostics and Biosecurity from weeds to Ebola.
Rob has broad ranging public health experience including;
He was a member of the Safety and Quality Outcomes Committee of the Hospital Innovation Reform Council, a member of the Victorian Quality Council and Member of the Health Advisory Committee of the National Health and Medical Research Council. His directorships are detailed below.
Rob is the current Chair of BioGrid Australia.
Director, Grenfell Health Consulting (1997 – present)Director, Maree Stopes Health (2011 - 2016)Chair, General Practice Victoria (2007 - 2010)Director, General Practice Victoria (1998 – 2007)
BA Bus (Hons), MBA, MAICD, FIML
Company Secretary since February 2015
Current Role: Chief Executive Officer, BioGrid Australia, since 2012
Maureen is responsible for the strategic and operational management of BioGrid Australia, its membership and key stakeholders. Utilising her extensive commercial experience, Maureen directs infrastructure and data management strategies to enable researchers to dynamically extract and analyse real-world data to empower data-driven health care decisions.
Prior to her current role Maureen held senior management positions in Operations and Commercial Risk, Business Development and Marketing across a number of industry sectors including finance with Ford Motor Company, auditing with Lloyd’s Register Quality Assurance, sports facility management and music education.
Between 2001 and 2011, Maureen was a non-executive director of the Australian Institute of Management – Victoria & Tasmania (now known as Institute of Managers and Leaders), where for the last four years of her tenure she was the Board Deputy Chair. In addition, Maureen was a member of the Finance, Audit and Risk Committee for seven years.
Maureen is the current Company Secretary of BioGrid Australia.
BSc, PhD, GradDipBus, FACHI, CHIA, GAICD
Director of BioGrid Australia since August 2018; Deputy Chair since September 2018Current Role: Director, Calliston Consultants Pty Ltd, 2016 to present
Paul obtained his PhD at Melbourne University, and a Graduate Diploma Business (Organisational Development) at RMIT University. He is a Fellow of the Australasian Society of Health Informaticians and a Certified Health Informatician (Australia). He is Deputy Chair BioGrid Australia and Associate Professor Health Informatics at Deakin University. He is an Editor for Pomegranate podcast of the Royal Australasian College of Physicians.
Paul specialises in independent strategic advisory services aimed at helping organisations make the most effective use of information and digital capabilities. Paul believes strongly in the benefits of diversity and has been a diversity champion throughout his career.
Paul is the current Deputy Chair of BioGrid Australia.
Secretary, Health Informatics Society Australia, Victorian Branch (2017 – present)Director, Digital Health, Department of Health and Human Services, Victorian Government (2017 – 2018)Director, Victorian Continence Resource Centre (2015 – present)
AM, B Comm, MBA, FCPA, FIML, MAICD
Director of BioGrid Australia since March 2014Current Role: Principal, Hodgson Associates since 2009
Chris has held six executive CEO roles, across hospitals/health services, legal firms and accounting & financial services firms. His most recent executive role was as part-time Executive Director of the Skin & Cancer Foundation Inc. This role was was complemented by 10 years consulting as a principal of Hodgson Associates. His consulting work covers primarily mid-sized professional services organisations in governance, strategy and business development governance.
With a long history in contributing to the Community, Chris has held directorships with Philanthropy Australia, Australian Communities Foundation, Arts Access Victoria, and currently the Melba Opera Trust (in addition to BioGrid Australia), refer to directorship listing below.
In 2019 Australia Day honours, Chris was awarded an AM (Member, Order of Australia) for his significant services to community through medical research organisations including BioGrid Australia. The award specifically refers to his leadership of the global Human Variome Project, where he led the organisation for three years as Chair.
Director, Melba Opera Trust (2017 – present)Principal, Hodgson Associates (2009 - present)Director, Skin & Cancer Foundation Inc (2009 – 2020)Chair, Global Variome Ltd (2016 – 2017)Chair, Human Variome Project International Ltd (2014 – 2017)Director, Christ Church Grammar Foundation (2012 - 2018)Chair, Telediagnostics Pty Ltd (2010 - 2016)Director, Human Variome Project International Ltd (2008 – 2017)Director Philanthropy Australia (2003 - 2009)Director Australian Communities Foundation (1999 - 2007)
Director of BioGrid Australia since August 2018; Chair, Business Advisory Committee since September 2018Current Role: Chief Operating Officer, Murdoch Children’s Research Institute, 2016 – present
James is Chief Operating Officer at Murdoch Children’s Research Institute (MCRI), one of Australia’s largest research institutes with close to 2000 researchers working across all areas of child and adolescent health.
Prior to this he was General Manager – Business Development & Strategy at MCRI, where he led the development and commercialisation of a pipeline of more than 400 research projects on new drugs, devices, diagnostics and digital health technologies.
James championed MCRI’s drive into digital health and has positioned the Institute as an international leader in this area. He led the development and implementation of a new model in medical research that facilitates greater collaboration and knowledge transfer across health and technology, engineering and ICT sectors.
James has over 17 years’ experience in health and medical research, both as a research scientist and in technology innovation and commercialisation. Previously, James was Business Development Manager at the Walter & Eliza Hall Institute in Melbourne, where he led a number of strategic collaborations with industry partners ranging from SMEs, to top 5 international pharmaceutical and Fortune 500 companies.
As a research scientist he was part of a team that developed a first-in-class vaccine for celiac disease that went on to raise over $35 million and is now in clinical trials. His work has resulted in the filing of three patent applications, two of which have been commercialised. James is currently a Non-Executive Director of GI Therapies, an unlisted spin-out from MCRI, refer to directorships listed below.
James is the current Chair of the Business Advisory Committee, a sub committee that reports to the Board.
Director, Prota Therapeutics (2016 – present)Director, GI Therapies (2012 – present)
B Bus, CA, CTA, MAICD, FGIA
Director of BioGrid Australia since January 2015; Chair, Finance, Audit and Risk Committee since October 2017Current Role: Director, DRP Consulting Pty Ltd, since 1996
David has over 35 years’ experience in accounting and business. David’s career spans running his own private practice to working with mid to top-tier firms.After merging his successful private practice with Nexia Australia in 2011 (which rebranded to Moore Stephens in 2015), he was appointed as a Director in the Business Advisory division, refer to directorship listing below.
Currently, David is the Managing Director of DRP Consulting Pty Ltd, which provides accounting, taxation, superannuation and consulting services to businesses, professionals and high net worth families. David provides these services across private, commercial and not-for-profit industry sectors, including professional services, health and medical, architecture and construction, IT and biotech.
David’s community leadership contribution includes current non-executive directorships with BioGrid Australia and Spirit of Australia Foundation.
David is the current Chair, Finance, Audit and Risk Committee, a sub committee that reports to the Board.
Director, Spirit of Australia Foundation (2018 to present)Director, Private Ancillary Funds (various to present)Director, Moore Stephens (Vic) Pty Ltd (formerly Nexia Melbourne Pty Ltd), (2011-2017)
MBBS, PhD, FRACP, FAHMS
Director of BioGrid Australia since March 2020Current Roles: Professor of Gynaecological Cancer, The University of Melbourne;Joint Division Head, Clinical Translation Centre and Laboratory Head, Walter and Eliza Hall Institute of Medical Research (WEHI);Medical Oncologist, Peter MacCallum Cancer Centre, Royal Melbourne and Royal Women's Hospitals.
Clare heads the Ovarian and Rare Cancers Laboratory at the Walter and Eliza Hall Institute of Medical Research. She has 20 years’ experience in treating breast and ovarian cancer and in clinical cancer genetics in Familial Cancer Clinics. Clare has been Principal Investigator for more than ten cancer clinical trials of targeted therapy. In the laboratory, Clare has developed ovarian and other rare cancer pre-clinical models and is using genomics to study targeted drug combinations to combat drug resistance.
Clare has established a rare cancer research program to improve access to targeted treatments for patients diagnosed with a rare cancer. Clare was awarded the Sir Edward Dunlop Cancer Research Fellowship from Cancer Council Victoria (2012) and a Clinical Research Fellowship from the Victorian Cancer Agency (2011, 2017). In 2018, Clare was recognized for her work in gynaecological cancers with the Jeannie Ferris Recognition Award from Cancer Australia.
Clare’s contribution to the community is reflected by her instigation of and participation in the WEHI’s Consumer Advisory Panel, now a leading example of involvement of the public in a Medical Research Institute. Clare also leads CART-Wheel.org, a BioGrid Australia platform for consumer data entry for people with a rare cancer who would like to participate in data collection for research.
Chair, Clinical Oncology Society Australia (COSA) Rare Cancer Group (2015 – present)Chair, International Rare Cancer Initiative (IRCI) Board (2020 – present) (Member, 2015 – present)Co-Chair, Gynaecologic Cancer Intergroup (GCIG) Rare Tumour Committee (2018 – present)Director, Australia New Zealand Gynaecology Oncology Group (ANZGOG) (2014 – present)Director, Cure Cancer Australia Foundation (2010 – 2020)Member Representative (WEHI), BioGrid Member Management Committee (2009 – present)
BA, MSc, PhD, GCUT
Director of BioGrid Australia since August 2016Current Role: Deputy Head Research, School of Computing and Information Systems, The University of Melbourne 2015 – present
Karin is Deputy Head Research, School of Computing and Information Systems, and Deputy Director of the Health and Biomedical Informatics Centre, The University of Melbourne. She has extensive experience in text and data analytics in biomedicine. Trained as a computational linguist, her contributions range from formal representation of biomedical data to machine learning over biological databases and analysis of social media for public health purposes.
She has published in journals including Nature Methods, Bioinformatics, and BMC Bioinformatics. Her group’s 2014 article in BMC Bioinformatics was selected as a Best Paper in the 2015 Yearbook of Medical Informatics. She held previous posts as the Scientific Director of Health and Life Sciences at NICTA Victoria Research Laboratory, at the University of Colorado School of Medicine, at Los Alamos National Laboratory, and in AI start-ups, refer to directorship listing below.
Deputy Director, ARC Industrial Transformation Training Centre in Cognitive Computing for Medical Technologies (2018 – present)Fellow, Centre for Business Analytics, Melbourne Business School (2015 – present)Deputy Director, Health and Biomedical Informatics Centre, University of Melbourne (2014 – present)President, Australasian Language Technology Association (ALTA) (2013 - 2014)Scientific Director, Health and Life Sciences, National ICT Australia (NICTA) (2012 – 2014)
+61 3 9342 2690
For technical difficulties using SAS to access BioGrid Australia data, please contact our Help Desk during office hours.
© 2021 BioGrid Australia